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Pharmacokinetics of Topically Applied Radiolabeled Retinoids in 
Hairless Mouse Epidermis and Dermis After Single Applications 
MICHAEL J. CONNOR, PH.D., MARY L. LINDAE, M.D.,* AND NICHOLAS J. LOWE, M.D., M.R.C.P. 
Division of Dermatology, Department of Medicine, UCLA School of Medicine, Los Angeles, California, U.S.A. 
The retention of tritium-labeled all-trans-retinoic 
acid (RA), 13-cis-retinoic acid (13-cis-RA), aromatic 
retinoid, and arotinoid ethyl ester in the epidermis and 
dermis of hairless mice was measured up to 24 h follow-
ing a single topical application in an acetone vehicle. 
The radioactivity in the tissues was extractable with 
chloroform:methanol, and the identities of the radioac-
tive species extracted were confirmed as retinoids using 
thin-layer chromatography. 
All the retinoids were absorbed into the skin rapidly. 
After an initial period of distribution and penetration 
(lasting for about 1 h) the amount of the applied retinoid 
remaining in the epidermis and dermis decreased more 
slowly, obeying first order (exponential) decay kinetics. 
Both the arotinoid and the aromatic retinoid persisted 
for longer in the epidermis than equivalent doses of RA 
or 13-cis-RA. The half-lives of the retinoids in the der-
mis tended to be longer than in the epidermis, except for 
the arotinoid. Aromatic retinoid persisted for longest in 
the dermis with a half-life of 11 h. 
Although retinoids are used in the treatment of a variety of 
s kin diseases, the molecular basis for t heir actions, outside of 
their role in vision, remains obscure. Epithelial tissues are 
particular ly responsive to retinoids, and t hey can exert a pro-
nounced impact on epidermal physiology and biochemistry. 
Of the many possible molecular sites of action proposed for 
retinoids their ab ility to inhibit t h e expression of ornithine 
decarboxylase (ODC) activity [1], which can be induced in t he 
epidermis by treatment with tumor promoters and carcinogens 
or by wounding stimuli suc h as tape-stripping, has remained 
one of the more attractive. The mechanism involved in this 
inhibition remains unknown, but appears to be a direct effect 
of the retinoids on a late transcript ional [2] or a posttransla-
tional [3) event. When a ll -trans-retinoic acid (RA), 13-cis-
retinoic acid (13-cis-RA), aromatic retinoid, or arotinoid ethy l 
ester (arotinoid) were applied topically to the dorsal skin of 
hairless mice 1 h before the mice were tape-stripped t he increase 
in ep idermal ODC activity found 4- 5 h after tape-stripping was 
much reduced. However, when the retinoids were applied 24 h 
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Abbreviations: 
aromatic retinoid: ethyl-all -trans-9-(4 -methoxy-2,3,6-trimethyl· 
phenyl) -3,7 -dimethyl -2,4 ,6,8-nonatetraenoate 
aroti noid ethyl ester: ethyl-p-[ (E) -2-(5,6,7,8-tetrahydro-5,5,8,8-te· 
tramethyl -2- naphthyl) -1 -propenyl] -benzoate 
13-cis-RA: 13-cis-retinoic ac id 
ODC: ornithine decarboxylase (L-orn ith ine carboxy-lyase, EC 
4.1.1 .1 7) 
RA: all -trans-retinoic acid 
TLC: t hi n-layer ch romatography 
before tape-str ipping only t he aroti noid inhibited the expres-
sion of ODC activity [4). These results suggested t hat t he 
retinoids e ither produced a short-lasting response, or did not 
remain for long in the epidermis. Few pharmacokinetic studies 
of retinoid uptake or loss from the skin have been reported. 
We t herefore performed t he following investigation, in which 
t h e loss of 4 radiolabeled retinoids from the epidermis and 
dermis of hairless mice were measured following single topical 
applications. 
MATERIALS AND METHODS 
Materials 
All-trans-retinoic acid, 13-cis-RA (isotretinoin, Ro 4-3780), arotinoid 
ethyl ester (Ro 13-6298), aromatic retinoid (etretinate, Ro 10-9359), 
and tritiated arotinoid ethyl ester and aromatic retinoid (specific radio-
activity 3.35 Ci/mmol and 0.38 Ci/mmol, respectively) were gifts from 
Hoffmann-La Roche (Nutley, New Jersey). [11 -3H ]All -trans-RA (spe-
cific radioactivity 1.51 Ci/mmol) and [113H]13-cis-RA (specific radio-
activity 1.56 Ci/mmol) were kindly provided by the National Cancer 
Institute (Biological and Chemical Prevention Program). NCS tissue 
solubilizer and OCS liquid scinti llation cocktail were bought from 
Amersham (Arlington Heights, Illinois) . Hairless (skh/hr1) female 
mice (8- 10 weeks old) originating from the Skin Cancer Hospital 
(Temple Universtity, Philadelphia, Pennsylvania) were used through-
out. 
Treatment of Mice with Retinoids 
The retinoids were applied topically in acetone as previously de· 
scribed [4,5]. Solutions of RA, 13-cis-RA, arotinoid ethyl ester, and 
aromatic retinoid were dissolved in acetone immediately before use. 
Retinoid solutions (0.2 ml containing 1- 2 ILCi of radioactivity where · 
appropr iate) were applied to t he dorsal skins of t he mice over an area 
approximately 15 cm2• All procedures were performed under subdued 
light to reduce the risk of photodegradation . The tota l amount of 
retinoid applied to each group of mice was varied between 2- 100 nmol. 
Mice were painted with retinoid solutions in groups of 3- 5 and sacri-
ficed 0.1-24 h late r. 
Preparation of Mouse Epidermis and Derm~~ 
Mice were killed by cervical dislocation and the dorsal skins removed. 
The skins were spread even ly over a glass plate and imprinted in 2 
separate areas with a 1.6 em-diamete r punch. The skins were immersed 
in water (50 ml) at 56"C for 35 s, cooled in ice/water, blotted dry with 
filter paper and placed on a cooled glass plate, and the epidermis within 
the punch outlines lifted off the dermis with a scalpel blade. The 
underlying dermis was cut free from the remaining skin with scissors. 
This procedure produced duplicate 2.0 cm2 disks of epidermis and 
dermis from each mouse. The disks were weighed and dissolved by 
incubating overnight at 37"C in 1.0 ml of NCS tissue solubilizer; 10 ml 
of OCS scintillation cocktail was added and the radioactivity deter-
mined by counti ng in a Beckman scinti llation counter at a counting 
efficiency of 60%. The remaining pieces of skin were extracted for 
qualitative examination of the retained radioactivity (see below). Ali· 
quots of the water used in the separation of the epidermis and dermis 
were counted to observe any loss of radioactivity from t he t issues 
through wash-off. 
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Tissue Extraction and Thin-Layer Chromatography (TLC) 
To minimize degradation of the retinoids during handling, all pro-
cedures were performed in the dark or under yellow light. Epidermal 
and dermal samples were weighed and homogenized in a minimum of 
10 volumes of ice-cold chloroform:methanol (1:1). The homogenates 
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were cent ri fuged at 1000 rpm for 5 min and the supernatants decanted. 
The pellets were reextracLed by being resuspe nded in 10 volumes of 
ice-cold chloroform:methanol (1:1) and agitated for 20 min . The sus-
pensions were centrifuged at 1000 rpm for 5 min and the supernata nts 
recovered. The amounts of radioactivity in the first and second super-
natants, and the pellets were determined. 
The chloroform:metha nol ext racts (wi th nonlabeled retinoids added 
as carriers and ma rkers) were chromatographed in the dark on chlo-
roform -washed heat-activated 0.05 mm -thick silica gel TLC plates, 
developed to about 20 em with hexane:ether:acetic ac id (90:10:1) or 
metha nol:chloroform (1:1) solvents. The distribut ion of radioactivity 
was measured by scraping 1-cm st rips of s ilica off the plates into vials 
conta ining 10 ml OCS, and t.he radioactivity coun ted in t he scin t illation 
cou nte r a fter refri gerating t he via ls overnight. Preliminary studies 
showed t hat t he sma ll amounts of radioactivity in t he second ext racts 
were quali tatively similar to those of the first ext racts, and the pha r-
macokinetic data were t herefore calculated using the chromatographic 
behavior of the first ext racts. 
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FIG 1. Cuta neous levels of RA fo llowing topica l application of t ri -
t iated RA to ha irless mice. Each value is the mean ± SD for samples 
from at least 3 animals and each animal received 10 nmol RA. The 
closed circles a re the va lues for t he epidermal and the open circles fo r 
t he de rmal RA levels; t he solid lines a re t he regression lines. 
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Calculation. af Pharmacokin.etic Parameters 
The t issue retinoid concentrations were calculated by determining 
the tota l radioactivity of the epidermal and dermal disks, converting 
t his to picomoles of retinoid using t he known specific radioactivities of 
the start ing materials, and correcting the value for the percentage of 
the radioactivi ty in t he tissue ext racts which behaved as t he starting 
compound on chromatography. The concent rations were expressed as 
pmol/mg wet weight . The epidermal and dermal concent rations were 
also compared directly by expressing the retinoid content in pmol/cm2 
and calcula ting the rat io of t he retinoid content of t he epidermal disks 
to that of t he immediate underlying dermis. 
The elimination half-lives (in hours) of t he retained retinoids were 
calculated by (exponent ial) regression analysis, plotting log. concent ra-
tion against t ime, using the most linear portion of the curve (usually 
between 1 and 24 h). The eliminat ion rate constants (K ) were computed 
from the slopes of the regression lines, and t he half-lives derived from 
these using t he equation K = 0.693/ half-life. E xt rapolation of the lines 
generated to zero t ime gave the theoretical (derived) maximum retinoid 
content of t he epidermal and dermal compart ments being studied. 
Differences between half-lives were assessed by comparing t he SE of 
t he estimates at a confidence level of 95 %. 
RESULTS 
A time course for the loss of RA from the epidermis and 
dermis is shown in Fig 1; similar t rends were found at t he other 
doses used and for the other retinoids. An init ia l period of rapid 
loss, attributable to distribut ion and penetration t hrough the 
skin, was followed by a period of slower exponent ial loss. This 
latter period (1 - 24 h) was used to calculate t he elimination 
half-lives of t he retained retinoids. 
The rate constants and half-lives for t he elimination of t he 
retinoids are given in T able I. The correlat ion coefficients 
obtained in the regression analysis ranged from 0.88-1.00, and 
in all cases the correlations were significant (p < 0.05), showing 
a good fit of t he resul ts to the regression equation used, i.e., 
that the elimination kinetics between 1- 24 h were first order. 
T ABLE 2. Metabolism of the radiola.beled retin.oids 
Percent extracted radioactivity cochromatographi ng 
with the sta rting compound" 
Hetinoid 1 Hour 8 Hours 24 Hours 
Epidermis Dermis Epide rmis Dermis Epidermis Dermis 
RA (10 nmol) 83 94 68 73 49 54 
Ra (1 00 nmol) 85 94 82 73 56 39 
13-cis-RA (10 
nmol) 94 86 88 76 52 67 
Aromatic retinoid 
(100 nmol) 96 95 94 89 92 90 
Arotinoid ethyl 
ester ( 10 nmol) 96 96 95 95 92 78 
" R1 values of t he standards in solvent 1 and solvent. 2 are: RA, 0.32 
and 0.89; 13-cis-RA, 0.36 and 0.94; aromatic retinoid, 0.52 and 0.99; 
aromat ic retinoid (free ac id) , 0.29 a nd 0.92; arotinoid ethyl ester, 0.72 
and 0.99; arotinoid free ac id, 0.28 and 0.90. 
TABLE I. The disappearance of tritium-labeled retinoids from the epidermis and dermis of hairless mice fol/.owing topical application 
Half-life" Hate constant. Derived max imum content a 
Hetinoid (h) (per h) (pmol/mg) 
Epiderrnis Dermis Epidermis Dermis Epidermis Dermis 
2 nmol RA " 2.3 ± 0.2 2.7 ± 0.1 0.31 0. 26 4.93 ± 0.52 0.13 ± 0.01 
10 nmol RA 3.0 ± 0.2 4.6 ± 1.1 0.23 0.15 25.0 ± 2.1 7 0.33 ± 0.05 
60 nmol RA 3.4 ± 0.4 4.9 ± 0.7 0.20 0.14 209 ± 65 2.85 ± 0.28 
100 nmol RA 3.2 ± 0.2 5.0 ± 0.3 0.21 0. 14 565 ± 100 5.0 ± 0.62 
10 nmol13-cis-RA 3.3 ± 0.8 4.9 ± 1.3 0.21 0.14 19.4 ± 12.4 0.32 ± 0.15 
140 nmol13-cis-RA 3.3 ± 0.3 5.0 ± 0.6 0.21 0. 14 352 ± 82 6.21 ± 1.39 
10 nmol arotinoid ethyl ester 6.4 ± 0.8' 5.3 ± 1.2 0. 11 0. 13 53.4 ± 10. 1 1.13 ± 0.42 
100 nmol a romatic retinoid 5.0 ± 0.4 ' 11.4 ± 4.0 0. 14 0.06 695 ± 99 6.77 ± 0.37 
" Values± SE of the estimate. 
b Values determined using data over the t ime period 1- 8 h only. 
' S ignifica nt ly higher t ha n an equivalent dose of RA and 13-cis- RA at t he 95 % confidence limits. 
186 CONNOR, LINDAE, AND LOWE 
The arotinoid persisted for longer than equivalent doses of RA 
or 13-cis-RA in the epidermis (half-lives of 6.4, 3.0, and 3.3 h, 
respectively), as did aromatic retinoid (half-lives of 5.0, 3.2, and 
3.3 h, respectively). Except for the arotinoid the half-lives in 
the dermis tended to be longer than in the epidermis. Aromatic 
retinoid persisted the longest in the dermis with a half-life of 
11.4 h. Generally the ratio of epidermal to dermal retinoid per 
unit area decreased with time, and the decrease was greater at 
the higher doses. 
Almost all (about 95 %) of the radioactivity in the tissues was 
recovered in the firs t extraction with hexane:chloroform, and 
the remaining 5% in the second. In samples with sufficiently 
high levels of radioactivity for chromatographic analysis of the 
second extract, the chromatographic properties of the first and 
second extracts were identical extracts. Negligible amounts of 
radioactivity were found in the water used in the separation of 
epidermis and dermis, even at 0.1 h, showing that wash-offwas 
not a source of error. The earlier the mice were sacrificed after 
application of t he retinoid the higher the recovery of radioac-
t ivity cochromatographing with the starting retinoid (Table II) . 
The chromatographic identification of the retained retinoids 
was limited, since the lability of the retinoids prevented the use 
of multiple solvent systems, and considerable concentration of 
dermal extracts was required to obtain suitable amounts of 
radioactivity, particularly at the later times. However the sys-
tems used separated all the sta rting retinoids from each other 
(Table II), although for the isomers RA and 13-cis-RA the 
resolution was slight. The results are presented in Table II. 
No attempt was made to characterize further the unknown 
radiolabeled derivatives present in the extracts, with the excep-
tion of the extracts from mice treated with arotinoid ethyl ester. 
The small amounts of radioactivity not cochromatographing 
with the starting material behaved as a single species which 
comigrated in both solvent systems with arotinoid free acid. 
The bulk of the unidentified radioactivity in extracts from the 
RA and 13-cis-RA-treated mice behaved as a single species, 
which remained on the origin in solvent 1 and traveled with 
the front in solvent 2. An additional compound was present in 
small amounts in the epidermal and dermal extracts from mice 
given the highest doses of RA or 13-cis-RA (Rf = 0.55 in solvent 
1). None of the radioactive species extracted in these studies, 
other than the retinoids themselves, was present in the starting 
materials, and therefore they are either metabolites or degra-
dation products formed in situ. 
DISCUSSION 
The half-lives of the retinoids in the epidermis after topical 
application were of the order of 2- 6 h. The similarity of the 
half-lives after 10, 60, or 100 nmol RA, and for 10 nmol and 
140 nmol 13-cis-RA indicates that the doses used were below 
saturation, i.e., that the loss of retinoid from the epidermis was 
independent of the dose, as expected for a first order (exponen-
tial) decay process. 
The half-lives of the retinoids in the dermis tended to be 
longer than in the epidermis , suggesting that in the dermis the 
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mechanisms involved in handling the retinoids are different 
from the epidermis. This may reflect the higher fat content of 
the dermis, since retinoids are so lipophilic. Interestingly the 
half life of aromatic retinoid in the dermis was much longer 
than for the other retinoids, as would be expected from previous 
clinical reports on its relatively slow elimination [6], although 
in the epidermis it was eliminated at a similar rate to RA. Our 
chromatographic analysis suggested that it was metabolized 
less extensively than the other retinoids . 
The ratio of epidermal to dermal retinoid levels decreased 
with time, reflecting the faster elimination of retinoid from the 
epidermis, and possibly direct passage of retinoid from the 
epidermis to the dermis. The mechanism involved in the per-
cutaneous absorption of retinoids is unknown, but the rapid 
appearance of radiolabeled retinoid in the dermis following 
topical application suggests that retinoids can pass through the 
epidermis by an extracellular route. The arotinoid behaved 
anomalously, since the epidermal to dermal ratio was actually 
increased at 24 h, suggesting either a slower passage of retinoid 
from the epidermis to the dermis, or a more rapid degradation 
and/or loss of the arotinoid in the dermis. In view of the low 
content of the dermis at this time (Table I) the latter would 
seem possible, although metabolites other than the free acid 
were not observed. Biologic investigations of arotinoids are still 
few in number and little is known of their metabolism. 
The results of our study explain the inability of low doses of 
RA or 13-cis-RA to inhibit the induction of epidermal ODC 
activity when applied topically to mouse skin 24 h prior to 
tape-stripping, since by that time their levels have fallen 
through 8 half-lives to almost negligible amounts. The failure 
of the aromatic retinoid to inhibit epidermal ODC induction 
when applied 24 h prior to insult in contrast to arotinoid ethyl 
ester must reflect the much higher potency [4) of the arotinoid, 
since both had similar half-lives. 
We would like to thank Dr. C. E. Smith, Division of Cancer Cause 
and Prevention, National Cancer Institute and Hoffman-La Roche for 
gifts of the radiolabeled retinoids used in this study. 
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